Asia-Pacific region: Drug-resistant tuberculosis: collaborative regional leadership required

Burnet’s Dr Suman Majumdar has joined leading Australian tuberculosis physicians, Dr Ben Marais, Dr Justin Denholm and Professor Warwick Britton, in calling for urgent action to respond to the global challenge posed by drug-resistant tuberculosis (TB).

The Asia−Pacific region carries the bulk of the global TB burden (58 per cent), including the majority of all estimated multidrug-resistant (MDR) cases (54 per cent) (resistance to isoniazid and rifampicin).

A compelling editorial, published in the Medical Journal of Australia (MJA), highlights the urgent need for a collaborative regional leadership response. The complete editorial can be downloaded from here.

Announcement of the Australasian Tuberculosis Forum.

Source: Burnet Institute

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Suman Majumdar, Ben Marais, Justin Denholm and Warwick Britton

Published: March 20, 2014, 9:57 p.m.

Last updated: March 20, 2014, 11:11 p.m.

Print Share